Wendy Naimark

Wendy Naimark is an accomplished technology leader with extensive experience in the biomedical field, currently serving as Chief Technology Officer and Vice President of Research and Development at Ripple Therapeutics since January 2020. Prior to this role, Naimark held the position of Vice President of R&D at Interface Biologics, where the company focused on innovative biomedical polymer technologies. Naimark's previous experience includes serving as Senior Director of Clinical and Preclinical Sciences at 480 Biomedical, Inc., and occupying various roles at Boston Scientific, including Senior Manager of Global Clinical Sciences and Principal Scientist. Naimark holds a PhD in Biomaterials from the University of Toronto, along with post-doctoral fellowships in Polymer Science from the University of Massachusetts Amherst and Protein Polymer Engineering from Caltech.